CPT® Code 64615 is used to report chemodenervation of facial, trigeminal, cervical, and/or other head and neck muscles for chronic migraine treatment. The procedure involves injecting a chemodenervating agent, such as botulinum toxin, into specified muscle groups to reduce excessive muscle activity associated with chronic migraine.
The service is generally performed using multiple injections across designated head and neck muscle groups as part of an established treatment protocol.
Key Facts About CPT® 64615
- Service type: Chemodenervation procedure
- Treatment area: Facial, trigeminal, cervical, and other head and neck muscles
- Purpose: Treatment of chronic migraine
- Medication: Chemodenervating agent, such as botulinum toxin
- Procedure: Multiple injections into designated muscles
- Provider type: Physician or qualified healthcare professional
Common clinical indications:
- Chronic migraine
- Frequent migraine headaches requiring preventive treatment
- Patients who meet applicable criteria for botulinum toxin migraine therapy
- Headache disorders requiring chemodenervation as part of a treatment plan
When to Use CPT® 64615
CPT 64615 may be reported when a provider performs chemodenervation of the specified facial, trigeminal, cervical, and/or head and neck muscles for chronic migraine.
Examples:
- Administering botulinum toxin injections as preventive treatment for chronic migraine
- Performing a scheduled repeat chemodenervation treatment for an established chronic migraine patient
- Treating designated head and neck muscle groups according to an appropriate migraine injection protocol
Documentation should support the diagnosis, medical necessity, medication administered, injection sites, and procedure performed.
Documentation Requirements
Documentation supporting CPT 64615 should include:
- Patient identifiers and date of service
- Chronic migraine diagnosis and relevant history
- Frequency, duration, and severity of migraine symptoms when relevant
- Medical necessity for chemodenervation
- Medication or chemodenervating agent administered
- Injection sites and muscles treated
- Dose and distribution of the medication
- Patient response and any adverse effects
- Follow-up or ongoing treatment plan
Detailed procedure documentation helps establish medical necessity and supports appropriate coding and billing.
Reimbursement and Coding Considerations
- CPT 64615 represents chemodenervation of specified head and neck muscles for chronic migraine
- The drug product is generally reported separately using the applicable HCPCS code when required
- Units of the medication administered should be documented accurately
- Coverage criteria for chronic migraine treatment vary by payer
- Prior authorization may be required
- Practices should verify payer-specific medical-necessity, documentation, and billing requirements before submitting claims
- Wastage reporting, when applicable, should follow current payer and coding guidelines
Accurate documentation of the migraine diagnosis, injection sites, medication, and dosage is important for supporting the service.
How OptiMantra Supports Migraine Treatment Documentation
OptiMantra helps practices document migraine history, treatment procedures, medications, and follow-up care within the patient chart.
With OptiMantra, providers can:
- Document chronic migraine diagnoses and relevant clinical history
- Record chemodenervation procedures and injection details within the patient chart
- Document medications and treatment plans
- Use customizable chart templates for consistent procedure documentation
- Record patient response and follow-up recommendations
- Maintain organized longitudinal patient records
Keeping migraine history and procedure details within the same patient record helps providers maintain consistent documentation across recurring treatments.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
